ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 185 filers reported holding ASCENDIS PHARMA A/S in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $51,000 | +10.9% | 491 | 0.0% | 0.01% | +14.3% |
| Q2 2022 | $46,000 | -13.2% | 491 | +9.1% | 0.01% | 0.0% |
| Q1 2022 | $53,000 | +1.9% | 450 | +16.9% | 0.01% | 0.0% |
| Q4 2021 | $52,000 | -14.8% | 385 | 0.0% | 0.01% | -12.5% |
| Q3 2021 | $61,000 | +24.5% | 385 | +3.2% | 0.01% | +14.3% |
| Q2 2021 | $49,000 | -2.0% | 373 | -4.8% | 0.01% | 0.0% |
| Q1 2021 | $50,000 | -27.5% | 392 | -6.2% | 0.01% | -36.4% |
| Q4 2020 | $69,000 | – | 418 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
| Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
| Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
| Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
| Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
| Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
| Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
| Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
| Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
| Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |